Prenatal stress and early-life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male offspring

ABSTRACT With the growing use of selective serotonin reuptake inhibitor medications (SSRIs) for the treatment of depression during the perinatal period, questions have been raised about the longterm impact of these medications on development. We aimed to investigate how developmental SSRI exposure m...

Full description

Saved in:
Bibliographic Details
Published in:Developmental psychobiology Vol. 58; no. 4; pp. 427 - 438
Main Authors: Boulle, Fabien, Pawluski, Jodi L., Homberg, Judith R., Machiels, Barbie, Kroeze, Yvet, Kumar, Neha, Steinbusch, Harry W. M., Kenis, Gunter, Van den Hove, Daniel L. A.
Format: Journal Article
Language:English
Published: United States Blackwell Publishing Ltd 01-05-2016
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT With the growing use of selective serotonin reuptake inhibitor medications (SSRIs) for the treatment of depression during the perinatal period, questions have been raised about the longterm impact of these medications on development. We aimed to investigate how developmental SSRI exposure may alter affect‐related behaviors and associated molecular processes in offspring using a rodent model of maternal stress and depression. For this purpose, prenatally stressed or non‐stressed male offspring were exposed to fluoxetine (5 mg/kg/day) or vehicle, via lactation, until weaning. Primary results show that postnatal fluoxetine exposure differentially altered anxiety‐like behavior by increasing anxiety in non‐stressed offspring and decreasing anxiety in prenatally stressed offspring. In the hippocampus, developmental fluoxetine exposure decreased BDNF IV and TrkB mRNA expression. Prenatal stress alone also decreased escape behaviors and decreased hippocampal BDNF IV mRNA expression. These data provide important evidence for the long‐term programming effects of early‐life exposure to SSRIs on brain and behavior. © 2015 Wiley Periodicals, Inc. Dev Psychobiol 58: 427–438, 2016.
Bibliography:ark:/67375/WNG-342ZRTM7-Z
istex:A0A6819605B5D21985BABED08A84132A1D6423E0
Charge de Recherche position with Fonds de la Recherche Scientifique (FRS-FNRS)
ArticleID:DEV21385
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0012-1630
1098-2302
DOI:10.1002/dev.21385